Jacob Grønnegaard of FujiFilm Diosynth Biotechnologies discussed how the company’s unique cloning processes dramatically reduce project execution time, effort and expense at Emerson Exchange Immerse event. The result is intended to be one of the top medicine production facilities in the country. Hopefully, it won’t have to ramp up production for a virus vaccine to combat a worldwide pandemic, but if the time ever comes again, it will be scalable and ready.
Latest News
New Emerson USB Data Acquisition Technology Delivers Quality Insight to More Engineers
NI mioDAQ device empowers engineers with improved measurement capabilities and enhanced software integration to accelerate the development of...
Emerson to Help Drive Greater Industrial Edge Interoperability
Company brings deep legacy of driving industry standards to Margo initiative enabling more flexible, scalable automation for customers
New Emerson Flushing Ring Streamlines Ordering, Installation with Complete, Packaged Solution
TESCOM AGI Flushing Ring features modular assembly for flushing and bleeding applications in distillation towers, hydrotreaters and more
